Mario DiazNuila-Alcazar

Department of Cardiology, University Hospital Sabadell, Autonomous University of Barcelona, Barcelona, Spain and the International Society of Cardiovascular Pharmacotherapy

Articles by Mario DiazNuila-Alcazar

Oral Anticoagulation and Prognosis of Patients with Atrial Fibrillation After Ischemic Stroke: A Real-world Data Analysis

Mario DiazNuila-Alcazar, Daniel Valcárcel-Paz, Pablo Del Castillo-Vásquez, et al

Citation: European Cardiology Review 2017;12(2):95.

DOI:

https://doi.org/10.15420/ecr.2017:23:3
Secondary Prevention in Patients with Non Valvular Atrial Fibrillation and Previous Stroke. Is It Possible to Have an Appropriate INR Control?

Mario DiazNuila-Alcazar, Daniel Valcárcel-Paz, Marcel Santaló-Corcoy, et al

Citation: European Cardiology Review 2017;12(2):103.

DOI:

https://doi.org/10.15420/ecr.2017:23:12
Using Direct Oral Anticoagulants in Patients with Atrial Fibrillation: Assessment, Monitoring and Treatment Reversal

Antoni Martínez-Rubio, Mario DiazNuila-Alcazar, Anna Soria Cadena, et al

Published:

Citation: European Cardiology Review 2016;11(2):118–22

DOI:

https://doi.org/10.15420/ecr.2016:30:1